TH

Thomas Higgins

CEO

Prosetta Biosciences Inc

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Prosetta Biosciences Inc
Industry
research
Employees
24.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
64136628.0
Latest Funding
Series D

Technologies

Outlook Typekit Mobile Friendly Google Font API Google Tag Manager Google Maps Squarespace ECommerce WordPress.org Vimeo Remote AI

Keywords

biotechnology drug discovery pharmaceuticals antivirals anticancer cns disorders alzheimer parkinson als antibiotics life sciences biotechnology research therapeutics small molecules protein assembly pan-cancer viral inhibitors antiviral compounds respiratory diseases neurodegenerative diseases hiv inhibitors multi-protein complexes homeostasis restoration amyotrophic lateral sclerosis cancer therapeutics antibacterial agents viral capsid assembly host-pathogen interaction drug resistance pharmacokinetics non-toxic drugs anti-proliferative compounds proteostasis novel drug targets drug modulation neurodegeneration infectious diseases cell-free protein synthesis molecular pharmacology drug efficacy therapeutic candidates sars-cov-2 prion diseases proteins target modulation chemical biology antiviral resistance cancer cell lines biochemical pathways molecular targets viral life cycle pulmonary infections apoptosis regulation assembly inhibitors cancer moonshot biological regulation viral therapeutics pathogenic mechanisms medical diagnostic services health & medical laboratory testing

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans